Total Funding
88
96
Total FundingCorporate Round raised
Growth Score
-6 pts
Heat Score
20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
613
Inocras provides AI-driven genomic analysis focused on cancer and rare diseases.
- Jeong Seok Lee: Co-founder and Chief Innovation Officer
- Youngseok Ju: Director of Genome Insight Institute
About the Company
Inocras provides AI-driven genomic analysis focused on cancer and rare diseases. The company offers whole genome sequencing products, including CancerVision, RareVision, and MRDVision, alongside research services for pharmaceutical and biotechnology organizations through its CAP/CLIA-certified laboratory. Inocras employs a proprietary
bioinformatics pipeline to process genomic data, supporting insights for both clinical and research applications. The company integrates sequencing and computational analysis to enable precision health approaches based on individual genomic information.
